Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
120 participants
INTERVENTIONAL
2024-09-02
2026-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
All participants in the study take part in high-intensity strength training for 10 months.
In addition, half of the participants receive vitamin D3 at a dose of 4,000 IU/day.
The investigators hypothesize that training combined with vitamin D3 supplementation will be more effective in preventing osteoporosis than training alone.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vitamin D3 supplementation
Group receiving vitamin D3 at a dose of 4000 IU / day
Supplementation of vitamin D3
Supplementation of vitamin d3 at a dose of 4000 iu / day
Placebo supplementation
Vegetable oil as a placebo.
Placebo
Vegetable oil as a placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Supplementation of vitamin D3
Supplementation of vitamin d3 at a dose of 4000 iu / day
Placebo
Vegetable oil as a placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* female
Exclusion Criteria
* unstabilized cardiovascular disease,
* cognitive disorders,
* radiological treatment in the last 12 months,
* other contraindications to undertaking high-intensity strength training,
* diseases affecting the skeleton such as: Paget's disease, type I diabetes mellitus,
* taking medications affecting skeletal conditions including: long-term therapy with corticosteroids, thiazides, antiretroviral drugs,
* contraindications to taking vitamin D including: hypercalcemia, nephrolithiasis, sarcoidosis, lack of cholecalciferol hydroxylase activity in the liver and kidneys.
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mateusz Karnia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mateusz Karnia
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mateusz Karnia, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Gdansk
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Gdańsk, Faculty of Biology
Gdansk, Pomeranian Voivodeship, Poland
University of Gdańsk, Faculty of Biology
Gdansk, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NdS-II/SP/0449/2024/0
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
Komisja Bioetyczna-47/23
Identifier Type: -
Identifier Source: org_study_id